Compare Nuwellis Inc (NUWE) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Victoria's Secret & Co — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Victoria's Secret & Co trades at $87.1 (market cap $6.95B). The key difference: Victoria's Secret & Co is far larger — about 6376.1× Nuwellis Inc's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | VSXY | |
|---|---|---|
Market Cap | $1.09M | $6.95B |
Sector | Technology | Consumer Cyclical |
52-Week High | $527.46 | $88.50 |
52-Week Low | $2.80 | $18.72 |
Enterprise Value | -$722.58K | $9.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Victoria's Secret (VSXY) trades at $87.09, up 6.92% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows improving fundamentals with revenue stabilizing at $6.23B in 2025 and net income recovering to $165M. Analyst consensus is bullish with a $88.56 price target, and institutional interest is growing, evidenced by Bessemer Group's increased stake in Q1 2026.
The outlook remains positive driven by international expansion, particularly in China, and product innovation. Risks include competitive pressures in retail and margin volatility. With no sell ratings from analysts and strong shareholder support for management, VSXY presents a growth opportunity, though investors should monitor execution on guidance and macroeconomic impacts on consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
